Advanced search
Publication Cover
Acta Orthopaedica Volume 79, 2008 - Issue 1
Journal homepage
921
Views
9
CrossRef citations to date
0
Altmetric
Original papers

Money matters: what to look for in an economic analysis

Lea M Dijksman Department of Orthopaedic Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands
,
Rudolf W Poolman Department of Orthopaedic Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands
,
Mohit Bhandari Division of Orthopaedic Surgery, McMaster University, Hamilton, Ontario, Canada; Hamilton General Hospital, Hamilton, Ontario, Canada
,
Ron Goeree Division of Orthopaedic Surgery, McMaster University, Hamilton, Ontario, Canada; Program for the Assessment of Technology in Health (PATH), St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada
,
Jean-Eric Tarride Division of Orthopaedic Surgery, McMaster University, Hamilton, Ontario, Canada; Program for the Assessment of Technology in Health (PATH), St. Joseph's Healthcare Hamilton, Hamilton, Ontario, CanadaCorrespondence[email protected]
&
on behalf of the International Evidence–Based Orthopaedic Surgery Working Group Department of Orthopaedic Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands
Pages 1-11 | Received 16 Oct 2007, Accepted 27 Oct 2007, Published online: 08 Jul 2009

  • Barber J A, Thompson S G. Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ 1998; 317: 1195–200
  • Bozic K J, Saleh K J, Rosenberg A G, Rubash H E. Economic evaluation in total hip arthroplasty: analysis and review of the literature. J Arthroplasty 2004; 19: 180–9
  • Briggs A H, O'Brien B J. The death of cost-minimization analysis?. Health Econ 2001; 10: 179–84
  • Briggs A, Sculpher M, Dawson J, Fitzpatrick R, Murray D, Malchau H. The use of probabilistic decision models in technology assessment: the case of total hip replacement. Appl Health Econ Health Policy 2004; 3: 79–89
  • Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Handbooks for Health Economic Evaluation. Oxford University press. 2006
  • Bryan S, Williams I, McIver S. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals. Health Econ 2007; 16: 179–93
  • Buxton M J. Economic evaluation and decision making in the UK. Pharmacoeconomics 2006; 24: 1133–42
  • Buxton M J, Drummond M F, Van Hout B A, Prince R L, Sheldon T A, Szucs T, Vray M. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6: 217–27
  • Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies. Ottawa 2006
  • Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J, O'Hagan T. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005; 14: 339–47
  • Drummond M F, Jefferson T O. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996; 313: 275–83
  • Drummond M F, Richardson W S, O'Brien B J, Levine M, Heyland D. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1997; 277: 1552–7
  • Drummond M F, Sculpher M F, Torrance G W, O'Brien B J, Stoddart G L. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, New York 2005
  • Fenwick E, O'Brien B J, Briggs A. Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. Health Econ 2004; 13: 405–15
  • Fielden J M, Cumming J M, Horne J G, Devane P A, Slack A, Gallagher L M. Waiting for hip arthroplasty: economic costs and health outcomes. J Arthroplasty 2005; 20: 990–7
  • Garber A M, Phelps C E. Economic foundations of cost-effectiveness analysis. J Health Econ 1997; 16: 1–31
  • George B, Harris A, Mitchell A. Cost-effectivEness Analysis And The Consistency Of Decision Making: evidence from pharmaceutical reimbursement in australia 1991 to 1996. Pharmacoeconomics 2001; 19: 1103–9
  • Goeree R, Burke N, O'Reilly D, Manca A, Blackhouse G, Tarride J E. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin 2007; 23: 671–82
  • Gold M R, Siegel J E, Russel L B, Weinstein M C. Cost-Effectiveness in Health and Medicine. Oxford University Press, New York 1996
  • Gonano C, Leitgeb U, Sitzwohl C, Ihra G, Weinstabl C, Kettner S C. Spinal versus general anesthesia for orthopedic surgery: anesthesia drug and supply costs. Anesth Analg 2006; 102: 524–9
  • Goodacre S, McCabe C. An introduction to economic evaluation. Emerg Med J 2002a; 19: 198–201
  • Goodacre S, McCabe C. Being economical with the truth: how to make your idea appear cost effective. Emerg Med J 2002b; 19: 301–4
  • Gordois A, Posnett J, Borris L, Bossuyt P, Jonsson B, Levy E, de P G. The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thrombo-embolism following major orthopedic surgery. J Thromb Haemost 2003; 1: 2167–74
  • Kaplan R M, Alcaraz J E, Anderson J P, Weisman M. Quality-adjusted life years lost to arthritis: effects of gender, race,and social class. Arthritis Care Res 1996; 9: 473–82
  • Kocher M S, Henley M B. It is money that matters: decision analysis and cost-effectiveness analysis. Clin Orthop 2003; 106–16
  • Laupacis A, Feeny D, Detsky A S, Tugwell P X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146: 473–81
  • Liljas B, Karlsson G S, Stalhammar N O. On future non-medical costs in economic evaluations. Health Econ 2007
  • Lothgren M, Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ 2000; 9: 623–30
  • Manca A, Willan A R. ‘Lost in translation’: accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics 2006; 24: 1101–19
  • Manca A, Rice N, Sculpher M J, Briggs A H. Assessing gen-eralisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ 2005; 14: 471–85
  • Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 1997; 16: 33–64
  • Mooney A. Quality of life: questionnaires and questions. J Health Commun 2006; 11: 327–41
  • Nemeth G. Health related quality of life outcome instruments. Eur Spine J (Suppl 1) 2006; 15: S44–S51
  • Nyman J A. Should the consumption of survivors be included as a cost in cost-utility analysis?. Health Econ 2004; 13: 417–27
  • O'Brien B. Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?. Med Care 1996; 34: DS99–108
  • O'Brien B J, Briggs A H. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 2002; 11: 455–68
  • Oostenbrink J B, Koopmanschap M A, Rutten F F. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002; 20: 443–54
  • Polly D W, Jr, Glassman S D, Schwender J D, Shaffrey C I, Branch C K, Burkus J, Gornet M F. SF-36 PCS benefit-cost ratio of lumbar fusion comparison to other surgical interventions: a thought experiment. Spine 2007; 32: S20–S26
  • Reitman C A, Watters W C, III, Sassard W R. The Cell Saver in adult lumbar fusion surgery: a cost-benefit outcomes study. Spine 2004; 29: 1580–3
  • Ritter M A, Albohm M J. Overview: maintaining outcomes for total hip arthroplasty. The past, present, and future. Clin Orthop 1997, 344: 81–7
  • Robinson R. Cost-benefit analysis. BMJ 1993a; 307: 924–6
  • Robinson R. Cost-effectiveness analysis. BMJ 1993b; 307: 793–5
  • Robinson R. Cost-utility analysis. BMJ 1993c; 307: 859–62
  • Robinson R. Costs and cost-minimisation analysis. BMJ 1993d; 307: 726–8
  • Robinson R. Economic evaluation and health care. What does it mean? BMJ 1993e; 307: 670–3
  • Saleh K J, Gafni A, Saleh L, Gross A E, Schatzker J, Tile M. Economic evaluations in the hip arthroplasty literature: lessons to be learned. J Arthroplasty 1999; 14: 527–32
  • Slover J, Espehaug B, Havelin L I, Engesaeter L B, Furnes O, Tomek I, Tosteson A. Cost-effectiveness of unicompartmental and total knee arthroplasty in elderly low-demand patients. A Markov decision analysis. J Bone Joint Surg Am 2006; 88: 2348–55
  • Thompson S G, Barber J A. How should cost data in pragmatic randomised trials be analysed?. BMJ 2000; 320: 1197–200
  • Udvarhelyi I S, Colditz G A, Rai A, Epstein A M. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?. Ann Intern Med 1992; 116: 238–44
  • Weinstein M C, Stason W B. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716–21
  • Welte R, Feenstra T, Jager H, Leidl R. A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics 2004; 22: 857–76

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.